<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Analyst Downgrade on FinanClub</title>
    <link>https://finan.club/tags/analyst-downgrade/</link>
    <description>Recent content in Analyst Downgrade on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 05:02:14 +0000</lastBuildDate><atom:link href="https://finan.club/tags/analyst-downgrade/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>ROIV</title>
      <link>https://finan.club/us/roiv/</link>
      <pubDate>Mon, 11 Sep 2023 05:02:14 +0000</pubDate>
      
      <guid>https://finan.club/us/roiv/</guid>
      <description>score:95
Chances: Roivant Sciences ranks No. 25 on Fast Companyâ€™s list of the 100 Best Workplaces for Innovators, indicating a positive work environment. Roivant reports positive topline results from various clinical trials, demonstrating the potential for successful drug development. Lokavant, a Roivant spin-off, emerges with multiple industry partnerships to accelerate clinical research, which could drive future growth.</description>
    </item>
    
  </channel>
</rss>
